Revenue
$16.6m
+40.3% ↑ vs $11.8m
Strong property sales lifted PBT 31.4%, but operating cash flow swung to a NZ$6.5m outflow as receivables built and a one-off tax charge cut NPAT
Revenue context before the current result.
EBITDA margin across covered periods.
Operating cash flow across covered periods.
Operating working-capital absorption or release by reporting period.
Key metrics
HY24 vs HY23
Revenue
$16.6m
+40.3% ↑ vs $11.8m
EBITDA
—
— vs $5.8m
Net profit after tax
$2.7m
-46.0% ↓ vs $5m
Net cash inflow from operating activities
−$6.5m
Suppressed: metric quality flags mark this value as unsuitable for normal comparison.
Operating profit
$7.9m
+49.2% ↑ vs $5.3m
Profit before tax
$9.2m
+31.4% ↑ vs $7m
Cash and cash equivalents
$10.7m
-76.2% ↓ vs $45m
Total assets
$313.5m
+2.3% ↑ vs $306.5m
What changed
This matters because the underlying operating result was strong: revenue rose 40.3% to NZ$16.6m and PBT rose 31.4% to NZ$9.2m, both above Annolyse's historical baseline (3-period mean revenue growth -38.2%, PBT growth -37.5%).
Trade debtors rose 90.9% to NZ$6.9m, lifting receivable days to 76.1 from 55.7, well above the historical mean of 37.2 days.
Headline NPAT fell 46.0% to NZ$2.7m because the effective tax rate jumped to 70.2% from 28.0%, reflecting a one-off non-cash adjustment of NZ$3.9m disclosed by the company in connection with a tax change.
What matters
OCF moved NZ$9.0m the wrong way while PBT was rising, and the receivables build (NZ$3.3m) explains only a portion of the swing — the rest sits in development-site spending ahead of expected H2 settlements. The implication is that the strong PBT print is, for now, capital that has been redeployed into inventory and receivables rather than realised cash earnings.
Tax distortion is the cleaner-read issue, not the economic one. PBT growth of 31.4% is the appropriate operating read because the NPAT-to-PBT gap of 77.4 percentage points is fully explained by the disclosed one-off non-cash tax adjustment. Management has flagged that the adjustment does not affect performance or cash flow, which is consistent with the gap between PBT and NPAT.
Investment property segment swung sharply negative. Segment result fell from a NZ$0.5m profit to a NZ$3.2m loss on broadly flat revenue (NZ$1.3m vs NZ$1.2m). Residential land development carried the result with segment profit of NZ$5.9m (prior NZ$4.5m), but the investment-property reversal absorbed roughly half of that uplift and is not explained in the supplied excerpts.
Expectations
Annualising HY24 revenue gives NZ$33.2m, broadly in line with the FY23 base of NZ$30.8m, but the stated objective is to improve on 2023 results despite the tax adjustment, with management referencing sales expected to settle before year-end.
The release does not provide a forward-work backlog figure, contracted-but-unsettled sales, or quantified development pipeline. That means the path to beating FY23 rests on H2 settlements that are referenced but not sized in the supplied disclosures.
Quality of result
PBT growth of 31.4% is genuine and reflects increased property sales, and the dominant residential land development segment improved profitability on rising volume. However, none of that growth has converted to cash this half: free cash flow pre-lease was negative NZ$6.6m versus positive NZ$2.2m, taking FCF-to-NPAT to -241.0% from 43.0% (prior OCF-to-EBITDA was 43.0%). For a residential developer, an H1 working-capital build ahead of H2 settlements is typical, but the abnormal debtor-days reading (76.1 vs historical mean 37.2) suggests the build is heavier than the historical pattern.
ROE softened to 1.8% from 3.3%, within Annolyse's historical baseline (3-period mean 3.5%) but at the lower end. NPAT margin of 16.3% is below the historical range of 26.2%–48.1%, reflecting the tax distortion rather than operating margin compression — PBT margin of 55.4% sits within its normal range.
Unresolved
This briefing cannot assess the size or timing certainty of the H2 settlement pipeline because no contracted-sales or forward-work disclosure is provided.
Chat
Ask follow-up questions about CDL Investments New Zealand's HY24 result.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Open to load segment breakdown.
Open to load analytical metrics.
Open to load key metrics.
CDI H1 2024 Directors Review
HY24 / results presentationCDI H1 2024 Media Release
HY24 / media releaseCDI H1 2024 Results Announcement
HY24 / results announcementCDI H1 2024 Unaudited Financial Statements
HY24 / financial reportCDI H1 2023 Media Release
HY23 / media releaseCDI H1 2023 NZX Results Announcement
HY23 / results announcementCDI H1 2023 Unaudited Financial Statements
HY23 / financial reportCDI FY2023 Audited Financial Statements
FY23 / financial reportCDI FY2023 Media Release
FY23 / media releaseCDI FY2023 Results Announcement
FY23 / results announcementRelated insights
Cross-company views selected from the metrics in this briefing.
Earnings quality and statutory distortions
PBT and NPAT growth diverged by 77.4pp, with a distortion flag in the result.
Revenue growth context
Revenue growth was 40.3% for this reporting period.
ROE and capital efficiency
ROE was 1.8%, -1.5pp versus the prior comparable period.
Working-capital pressure
Debtor days were 76 days for this result.
Get the next CDL Investments New Zealand briefing and related NZX reporting-season updates by email.